C4B and neoplasm: Using the HA–CH–siPLXDC1 particles (150 mg/kg, IV twice per week), the authors showed a significant decrease in the level of PLXDC1 mRNA in the tumor mass compared to CH–control siRNA and CH–siPLXDC1.